[
  {
    "ts": null,
    "headline": "Elevance Health Inc. stock underperforms Friday when compared to competitors",
    "summary": "Elevance Health Inc. stock underperforms Friday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=f879f114c39755ff12d4becdfd32c6bbff42e8968b1f6b3a43d1ec0e110804df",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742575140,
      "headline": "Elevance Health Inc. stock underperforms Friday when compared to competitors",
      "id": 133317187,
      "image": "",
      "related": "ELV",
      "source": "MarketWatch",
      "summary": "Elevance Health Inc. stock underperforms Friday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=f879f114c39755ff12d4becdfd32c6bbff42e8968b1f6b3a43d1ec0e110804df"
    }
  },
  {
    "ts": null,
    "headline": "MDPL: No Reason To Pay Those Hefty Fees For Now",
    "summary": "Monarch Dividend Plus ETF holds a 30-stock portfolio focused on dividend growth. Click to see whether the MDPL ETF is worth the high fees that it charges.",
    "url": "https://finnhub.io/api/news?id=e190a321677a6e995cbdfbd70ffb28bfc381ae3e019d6d0c2da74065cfc3f916",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742571702,
      "headline": "MDPL: No Reason To Pay Those Hefty Fees For Now",
      "id": 133308268,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2185637836/image_2185637836.jpg?io=getty-c-w1536",
      "related": "ELV",
      "source": "SeekingAlpha",
      "summary": "Monarch Dividend Plus ETF holds a 30-stock portfolio focused on dividend growth. Click to see whether the MDPL ETF is worth the high fees that it charges.",
      "url": "https://finnhub.io/api/news?id=e190a321677a6e995cbdfbd70ffb28bfc381ae3e019d6d0c2da74065cfc3f916"
    }
  },
  {
    "ts": null,
    "headline": "The Davenport Value & Income Fund Q4 2024 Commentary",
    "summary": "The Davenport Value & Income Fund (DVIPX) generated a -4.18% total return in the fourth quarter of 2024. Click here to read the full commentary.",
    "url": "https://finnhub.io/api/news?id=acc71f70c7667d46baa00b01d18be97b49ba74c9cd24c97a89ae4335c5e76518",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742559600,
      "headline": "The Davenport Value & Income Fund Q4 2024 Commentary",
      "id": 133307048,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1365758819/image_1365758819.jpg?io=getty-c-w1536",
      "related": "ELV",
      "source": "SeekingAlpha",
      "summary": "The Davenport Value & Income Fund (DVIPX) generated a -4.18% total return in the fourth quarter of 2024. Click here to read the full commentary. ",
      "url": "https://finnhub.io/api/news?id=acc71f70c7667d46baa00b01d18be97b49ba74c9cd24c97a89ae4335c5e76518"
    }
  },
  {
    "ts": null,
    "headline": "Artisan Select Equity Fund Q4 2024 Commentary",
    "summary": "The non-Magnificent Seven share prices have lagged terribly over the past several years. But how have these companies done from an earnings perspective? Find out.",
    "url": "https://finnhub.io/api/news?id=b8ae97d119aebc7c089932c07790851c6034d92998e733633976c431871ddb9e",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742543700,
      "headline": "Artisan Select Equity Fund Q4 2024 Commentary",
      "id": 133297685,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1322205526/image_1322205526.jpg?io=getty-c-w1536",
      "related": "ELV",
      "source": "SeekingAlpha",
      "summary": "The non-Magnificent Seven share prices have lagged terribly over the past several years. But how have these companies done from an earnings perspective? Find out. ",
      "url": "https://finnhub.io/api/news?id=b8ae97d119aebc7c089932c07790851c6034d92998e733633976c431871ddb9e"
    }
  }
]